Identification of Biomarkers for Patients with Vascular Anomalies

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2050

Study Completion Date

December 31, 2050

Conditions
Vascular AnomalyGeneralized Lymphatic AnomalyKaposiform HemangioendotheliomaKaposiform LymphangiomatosisGorham-Stout DiseaseKlippel Trenaunay SyndromeCongenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
Trial Locations (2)

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

02115

TERMINATED

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

Lymphangiomatosis and Gorham's Disease Alliance (LGDA)

UNKNOWN

collaborator

Klippel Trenaunay (KT) Support Group

UNKNOWN

collaborator

CLOVES Syndrome Community Support Group

UNKNOWN

lead

Children's Hospital Medical Center, Cincinnati

OTHER